Intravacc: innovating vaccines
Intravacc appoints Dr Jan Groen as CEO
vaccsheet OMVs
Intravacc appoints Dr Jan Groen as CEO
vaccsheet 3R research
Intravacc appoints Dr Jan Groen as CEO
vaccsheet Vero cell platform
Intravacc appoints Dr Jan Groen as CEO
vaccsheet GMP facilities
Intravacc appoints Dr Jan Groen as CEO
vaccsheet Conjugates
Intravacc appoints Dr Jan Groen as CEO
Event Webinar
Intravacc Receives US NIH/NIAID Contract to Develop Enterovirus D68 Vaccine Bilthoven, The Netherlands, 8 September, 2020 – Intravacc, a global leader in translational research and development of viral and bacterial vaccines, today announced that it has been awarded a contract with base and options that may total US$9.4 million from the US National Institute of…
Event Congress
Intravacc Receives US NIH/NIAID Contract to Develop Enterovirus D68 Vaccine Bilthoven, The Netherlands, 8 September, 2020 – Intravacc, a global leader in translational research and development of viral and bacterial vaccines, today announced that it has been awarded a contract with base and options that may total US$9.4 million from the US National Institute of…
Event Webinar
Intravacc Receives US NIH/NIAID Contract to Develop Enterovirus D68 Vaccine Bilthoven, The Netherlands, 8 September, 2020 – Intravacc, a global leader in translational research and development of viral and bacterial vaccines, today announced that it has been awarded a contract with base and options that may total US$9.4 million from the US National Institute of…
